Correlation Between Emcure Pharmaceuticals and Paramount Communications

Can any of the company-specific risk be diversified away by investing in both Emcure Pharmaceuticals and Paramount Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emcure Pharmaceuticals and Paramount Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emcure Pharmaceuticals and Paramount Communications Limited, you can compare the effects of market volatilities on Emcure Pharmaceuticals and Paramount Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emcure Pharmaceuticals with a short position of Paramount Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emcure Pharmaceuticals and Paramount Communications.

Diversification Opportunities for Emcure Pharmaceuticals and Paramount Communications

0.0

Correlation Coefficient

Emcure Pharmaceuticals  Paramount Communications

Pay attention - limited upside

The 3 months correlation between Emcure and Paramount is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Emcure Pharmaceuticals and Paramount Communications Limit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paramount Communications and Emcure Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emcure Pharmaceuticals are associated (or correlated) with Paramount Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paramount Communications has no effect on the direction of Emcure Pharmaceuticals i.e., Emcure Pharmaceuticals and Paramount Communications go up and down completely randomly.

Pair Corralation between Emcure Pharmaceuticals and Paramount Communications

If you would invest  7,925  in Paramount Communications Limited on October 10, 2024 and sell it today you would earn a total of  366.00  from holding Paramount Communications Limited or generate 4.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.61%
Values	Daily Returns

Emcure Pharmaceuticals  vs.  Paramount Communications Limit

Emcure Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Emcure Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Paramount Communications

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Paramount Communications Limited are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady essential indicators, Paramount Communications may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Emcure Pharmaceuticals and Paramount Communications

The main advantage of trading using opposite Emcure Pharmaceuticals and Paramount Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emcure Pharmaceuticals position performs unexpectedly, Paramount Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paramount Communications will offset losses from the drop in Paramount Communications' long position.

The idea behind Emcure Pharmaceuticals and Paramount Communications Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.